IGN-301
N/A
Report date: 2022/03/14 18:05:44
Base Information
Drug NameIGN-301
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma AgClariant Produkte (Schweiz) Ag
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesIgeneon AgClariant Produkte (Schweiz) AgNovartis Pharma Ag
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksDrugBank